#USA #Tempe #GammaTile #GT Medical #Westchester Med

GT Medical Technologies Welcomes GammaTile® Center of Excellence Designation

In a significant advancement in the field of brain tumor treatment, GT Medical Technologies has announced that Westchester Medical Center has received the prestigious GammaTile® Center of Excellence designation. This honor highlights the dedication of Westchester's medical staff to providing exceptional patient care and its commitment to advancing innovative treatment methodologies for brain tumors.

The GammaTile Center of Excellence program recognizes institutions that demonstrate high levels of proficiency in executing the GammaTile procedure and meeting defined clinical benchmarks. Physicians and healthcare facilities that are awarded this designation, such as Westchester Medical Center, are acknowledged for their expert capabilities, encompassing rigorous case management, adherence to ongoing education programs, and a proven track record of successful patient outcomes in utilizing the GammaTile technology.

Expertise and Impact

Two notable physicians leading this initiative at Westchester Medical Center, Dr. Simon Hanft and Dr. Rohil Shekher, have been instrumental in furthering the understanding and application of GammaTile therapy. Dr. Hanft, a neurosurgeon specializing in oncology, expressed pride in the recognition, stating, "Receiving recognition as a GammaTile Center of Excellence is a meaningful acknowledgment of our team's dedication to advancing brain tumor treatment. We are committed to providing innovative options like GammaTile, which deliver targeted radiation therapy precisely where it’s needed while minimizing exposure to healthy brain tissue."

Dr. Shekher, a radiation oncologist and CNS Program Lead, reiterated this sentiment, emphasizing the collaborative efforts made to push the boundaries of current treatment protocols. They aim to enhance patient outcomes and ultimately provide hope to those affected by brain tumors and their families.

About GammaTile Technology

The GammaTile is a pioneering therapeutic tool that integrates radiation treatment into the surgical process. Unlike traditional methods that delay radiation therapy to allow for wound healing, GammaTile is implanted directly into the tumor cavity during surgery. This allows immediate radiation delivery directly to the cancerous area when cancer cells are most vulnerable.

Moreover, the technique significantly minimizes unnecessary radiation exposure to surrounding healthy tissues, which is a common concern with conventional treatment methods. With a design that incorporates bioabsorbable collagen implants coupled with radiation seeds, the GammaTile ensures localized treatment efficacy, helping to mitigate chances of cancer regrowth.

Since its full market introduction in March 2020, the GammaTile approach has rapidly gained recognition and adoption across more than 100 leading healthcare centers, reflecting its increasing acceptance in both academic institutions and community healthcare settings.

The implications of this technology extend beyond technical advancements; they signify a renewed commitment to patient-centered care. It allows medical professionals to offer state-of-the-art treatment options that can genuinely change patients' lives.

About GT Medical Technologies

GT Medical Technologies was founded with the clear intent of addressing unmet needs within the realm of brain tumor management. Their leadership team comprises specialized professionals dedicated to improving standards of care through continued innovation. The introduction of GammaTile exemplifies this commitment, bridging gaps in current approaches and enhancing the overall landscape of neuro-oncological treatment.

For further information on GT Medical Technologies and GammaTile, visit gammatile.com and follow their updates across social media platforms such as Facebook, Instagram, LinkedIn, and X. Together, they continue to strive for groundbreaking advancements that promise improved outcomes for patients fighting brain tumors.